Crispr Analysts Dazzled as Early Data Herald New Treatment Era

(Bloomberg) -- Crispr Therapeutics AG surged to the highest since May 2018 as analysts across Wall Street applauded early data using the next-generation gene-editing tool that shares the company’s ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.